Tiziana Life Sciences Plc Share Price

NASDAQ: TLSA

Small Cap

$1.66

-0.04

(-2.35%)

as on September 17, 2025 at 1:29 am IST

$₹

Tiziana Life Sciences Plc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$1.64
Day's Price Range
$1.75
$1.66
1.20%
Downside
5.42%
Upside
52 Week's Low
52 Week's High
$0.63
52-Week Price Range
$2.6
$1.66
62.08%
Downside
56.63%
Upside

Tiziana Life Sciences Plc share price movements today

Previous Close: $1.70
Open: $1.71
Volume: 790.3K
Day's Low - High: $1.64 - $1.75
52 Week Low - High: $0.63 - $2.6

Tiziana Life Sciences Plc Historical Returns

1 Month Return: -13.71 %
3 Month Return: + 8.97 %
1 Year Return: + 100 %
3 Year Return: + 209.09 %
5 Year Return: -54.3 %

Tiziana Life Sciences Plc Stock Fundamentals & Key Indicators

Check Tiziana Life Sciences Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$198.6M

EPS (TTM)

-0.133

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-15.8M

Revenue (TTM)

-3.6M

Profit Margin

0.00%

Return On Equity TTM

2783100.00%

Tiziana Life Sciences Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tiziana Life Sciences Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tiziana Life Sciences Plc	BUY	$198.6M	-54.3%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Tiziana Life Sciences Plc Stock including INR - Dollar returns

The Tiziana Life Sciences Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tiziana Life Sciences Plc investment value today

Current value as on today

₹2,00,162

Returns

₹1,00,162

(+100.16%)

Returns from Tiziana Life Sciences Plc Stock

₹95,294 (+95.29%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Tiziana Life Sciences Plc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Tiziana Life Sciences Plc. Average target price of $8.05

Tiziana Life Sciences Plc Share Price Target

Get share price movements and forecasts by analysts on Tiziana Life Sciences Plc.

What analysts predicted

79.38%UPSIDE

Target Price

$8.05

Current Price

$1.66

Analyzed by

7 Analysts

Target

$8.05

Tiziana Life Sciences Plc target price $8.05, a slight upside of 79.38% compared to current price of $1.66. According to 7 analysts rating.

Tiziana Life Sciences Plc Stock's Interest Amongst Investors

Search interest for Tiziana Life Sciences Plc Stock has increased by 55% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:55% versus previous 30 day period

Tiziana Life Sciences Plc Quarterly Profit & Loss

All numbers in Millions USD


Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Tiziana Life Sciences Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	0	0	0	0	-	-
Operating Income	-12	-7	-8	-7	-7	-28	-27	-14	-17	-15
EBITDA	-12	-7	-8	-7	-7	-27	-26	-15	-17	-
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-12	-7	-8	-7	-7	-28	-26	-15	-17	-16
Income Tax Expense	-	0	-1	-1	0	-2	-3	0	0	-
Net Income	-19	-8	-9	-7	-9	-35	-31	-18	-17	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tiziana Life Sciences Plc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023
Net Income	-17	-3	-3	-2	-4	-5	-5	-10	-4
Operating Cash Flow	-13	-4	-4	-5	-11	-3	-3	-7	-
Investing Cash Flow	0	0	0	-1	-1	0	0	0	-
Financing Cash Flow	0	0	0	0	0	0	0	0	-
Change in Cash	-12	-5	-5	-7	-26	-4	-4	-8	-

Tiziana Life Sciences Plc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-6	-6	-7	-26	-26	-15	-17	-11
Operating Cash Flow	-5	-5	-3	-5	-11	-21	-19	-15	-1
Investing Cash Flow	0	0	0	0	0	0	-3	-1	-
Financing Cash Flow	1	1	7	1	75	0	0	0	4
Change in Cash	-4	-4	4	-4	65	-23	-24	-16	2

Global Institutional Holdings in Tiziana Life Sciences Plc

Funds	Holdings
Dauntless Investment Group, LLC	1.49%
Jane Street Group LLC	0.14%
Omers Administration Corp	0.12%
Morgan Stanley - Brokerage Accounts	0.12%
HSBC Holdings PLC	0.09%

See all

Insights on Tiziana Life Sciences Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TLSA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, TLSA has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 1 month, TLSA stock has moved down by -13.7%

About Tiziana Life Sciences Plc

tiziana life sciences plc is a uk biotechnology company that focuses on the discovery and development of novel molecules that treat human disease in oncology and immunology. the company is focused on its lead compound, milciclib, a molecule which blocks the action of specific enzymes called cyclin-dependent kinases (cdk) involved in cell division as well as a number of other protein kinases. milciclib is currently in phase ii clinical trials for thymic carcinoma in patients previously treated with chemotherapy. the company is also in clinical development of foralumab. foralumab is the only fully human engineered anti-human cd3 antibody in clinical development. this phase ii compound has potential application in a wide range of autoimmune and inflammatory diseases, such as ulcerative colitis, multiple sclerosis, type-1 diabetes (t1d), inflammatory bowel disease (ibd), psoriasis and rheumatoid arthritis, where modulation of a t-cell response is desirable. tiziana life sciences’ research

Organisation	Tiziana Life Sciences Plc
Headquarters	14/15 Conduit Street, London, United Kingdom, W1S 2XJ
Industry	Health Technology
CEO	Dr. Ivor R. Elrifi Ph.D.
E-voting on shares	Click here to vote

Key Management of Tiziana Life Sciences Plc

Name	Title
Dr. William A. Clementi Ph.D., Pharm.D.	Chief Development Officer
Dr. Napoleone Ferrara M.D.	Member of Scientific Advisory Board
Mr. Gabriele Marco Antonio Cerrone M.B.A.	Founder & Executive Chairman
Dr. Ivor R. Elrifi Ph.D.	CEO & Executive Director
Ms. Keeren Shah	COO & CFO

FAQs

What is Tiziana Life Sciences Plc share price today?

Tiziana Life Sciences Plc share price today is $1.66 as on September 17, 2025 at 1:29 am IST at the close of the market. Tiziana Life Sciences Plc share today touched a day high of $1.75 and a low of $1.64.

What is the 52 week high and 52 week low for Tiziana Life Sciences Plc share?

Tiziana Life Sciences Plc share touched a 52 week high of $2.6 on August 1, 2025 and a 52 week low of $0.63 on December 31, 2024. Tiziana Life Sciences Plc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $1.66,which is 36.15% down from its 52 week high and 163.70% up from its 52 week low.

What is Tiziana Life Sciences Plc's market capitalisation today?

Tiziana Life Sciences Plc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Tiziana Life Sciences Plc Stock (TLSA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tiziana Life Sciences Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tiziana Life Sciences Plc Shares that will get you 0.9036 shares as per Tiziana Life Sciences Plc share price of $1.66 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tiziana Life Sciences Plc Stock (TLSA) from India?

Indian investors can start investing in Tiziana Life Sciences Plc (TLSA) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 11:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Tiziana Life Sciences Plc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 11:43 am IST). Based on Tiziana Life Sciences Plc share’s latest price of $1.66 as on September 17, 2025 at 1:29 am IST, you will get 6.0241 shares of Tiziana Life Sciences Plc. Learn more about fractional shares .

What are the returns that Tiziana Life Sciences Plc has given to Indian investors in the last 5 years?

Tiziana Life Sciences Plc stock has given -54.3% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?